Rugg D, Thompson D, Gogolewski R P, Allerton G R, Barrick R A, Eagleson J S
Merck Research Laboratories, Somerville, NJ 08876, USA.
Aust Vet J. 1998 May;76(5):350-4. doi: 10.1111/j.1751-0813.1998.tb12366.x.
To investigate the efficacy of ivermectin in an intraruminal controlled-release capsule (CRC) against blowfly strike.
Pen and field trials with controls.
Pen studies: Two breech strike trials involving 60 Romney and 60 Merino sheep. One body strike trial using 100 Merino sheep. Field trials: Eight trials in New Zealand used 1000 Romney and Romney-cross sheep. Fifty Merino lambs in one trial in Australia.
Pen studies: Sheep were allocated to two equal groups. One was not treated, the other sheep received a CRC that delivered ivermectin at > or = 20 micrograms/kg/day for 100 days. In the breech strike trials, each animal was given an oral laxative 2 days before exposure to adult Lucilia cuprina. In the body-strike trial, the sheep sheep were kept wet to increase susceptibility prior to the release of blowflies. Field trials: Fifty or 200 sheep allocated to equal groups of nontreated or treated with the CRC and grazed at pasture exposed to natural blowfly challenge.
Pen studies: Breech strikes developed in 24 of 60 controls but in none of 60 CRC-treated sheep. There was a 35% reduction in the number of CRC-treated sheep struck on the body. Field trials: The average number of breech strikes in CRC-treated sheep was reduced by 86% (P < 0.001). The number of body strikes in the treated groups was a reduced by 27% (P < 0.05).
The ivermectin CRC is a useful aid in controlling breech strike, but provides only moderate reduction in the incidence of body strike.
研究伊维菌素瘤胃内控释胶囊(CRC)预防蝇蛆病侵袭的效果。
设有对照的围栏试验和田间试验。
围栏试验:两项臀部侵袭试验,涉及60只罗姆尼羊和60只美利奴羊。一项体部侵袭试验,使用100只美利奴羊。田间试验:在新西兰进行的8项试验,使用1000只罗姆尼羊和罗姆尼杂交羊。在澳大利亚进行的一项试验中使用50只美利奴羔羊。
围栏试验:将绵羊分为两组,每组数量相等。一组不进行处理,另一组绵羊接受能以≥20微克/千克/天的剂量释放伊维菌素达100天的CRC。在臀部侵袭试验中,每只动物在接触成年铜绿蝇前两天口服泻药。在体部侵袭试验中,在释放苍蝇之前,保持绵羊体表湿润以增加易感性。田间试验:将50只或200只绵羊分为未处理组和CRC处理组,每组数量相等,在暴露于自然苍蝇挑战的牧场放牧。
围栏试验:60只对照羊中有24只发生臀部侵袭,而60只接受CRC处理的绵羊均未发生。接受CRC处理的绵羊体部侵袭数量减少了35%。田间试验:接受CRC处理的绵羊臀部侵袭平均数量减少了86%(P<0.001)。处理组的体部侵袭数量减少了27%(P<0.05)。
伊维菌素CRC在控制臀部侵袭方面是一种有用的辅助手段,但在降低体部侵袭发生率方面效果一般。